Roche to acquire Santaris Pharma for $450 million

Swiss pharmaceutical giant Roche says it plans to buy Denmark-based biotech company Santaris Pharma for up to $450 million, Reuters reported on August 4.

According to the report, Roche announced it would pay Santaris Pharma an initial amount of $200 million, and an additional $250 million upon reaching certain milestones. Roche hopes to acquire Santaris Pharma’s new class of drugs that can silence mRNA’s, which the company believes is a breakthrough in treating difficult to cure diseases.

Santaris Pharma is one of the many pharmaceutical company recently acquired by Roche. Last month, U.S.-based Seragon Pharmaceuticals Inc. was bought by Roche for $1.725 billion.

Acquisitions like this help you establish a stronger market foothold for your business. Let a qualified and seasoned Cedar Rapids business lawyer at Arenson Law Group, PC, represent your interests during acquisitions. To learn more about how we can be of help, call our offices at (319) 363-8199 today.